OPRX OptimizeRx Corp

Overview and Growth

OptimizeRx Corp generated $109.43M of revenue in fiscal 2025, with net income of $5.13M and an operating cash inflow of $18.71M. At $109.43M, the top line establishes the operating scale supporting the company’s profit and cash-flow profile. Compared with $92.13M in fiscal 2024, revenue recorded a 18.8% year-over-year increase. Diluted earnings per share were $0.27, translating the period’s attributable earnings into the amount reported for each diluted share. Revenue equaled 0.62x of total assets, indicating how much reported top-line activity the company produced relative to its period-end asset base.

Profitability

Gross profit was $73.59M, representing the portion of revenue remaining after the reported cost of revenue and before operating expenses. The gross-profit relationship equaled 67.3% of revenue, quantifying the portion retained before operating expenses were recognized. Operating income was $11.69M, the earnings remaining from reported operations after the company’s recognized operating cost structure. The operating result equaled 10.7% of revenue, placing the absolute operating-income figure in the context of the company’s sales base. Net income came to $5.13M, completing the progression from revenue through gross and operating profitability to the final reported result. The final earnings result represented 4.7% of revenue, connecting the absolute net income figure with the company’s top-line scale. Before income taxes, the company reported $6.95M of earnings, providing a bridge between the operating result and final net income. Measured against revenue, pretax income equaled 6.4%, adding a pre-tax profitability layer between revenue and net income. The company recognized $1.82M of income tax for the period, completing the transition from pretax income to net income. Relative to pretax income, the tax provision measured 26.2%, quantifying the portion of pre-tax earnings paid in income tax.

Liquidity and Capital Structure

The company held $176.92M of assets against $48.62M of liabilities and $128.29M of equity, revealing how the asset base was financed. At period end, current assets of $64.72M compared with current liabilities of $21.26M, defining the company’s short-term resource position. At 3.04x, the current ratio shows that short-term assets were greater than short-term liabilities at period end. Reported cash and equivalents were $23.36M, separating immediately recognizable cash resources from the rest of the current-asset base. Measured only with cash and equivalents, coverage of current liabilities was 109.9%, excluding receivables and other current assets. Borrowings totaled $25.68M, adding a fixed financing obligation alongside the company’s equity capital. The debt-to-equity relationship was 0.2x, showing how much debt the company carried for each unit of book equity. Debt represented 14.5% of total assets, placing borrowing in the context of the company’s full resource base. Relative to total assets, liabilities measured 27.5%, complementing the separate equity-based view of the company’s capital structure. Cash and equivalents equaled 13.2% of total assets, showing the liquid cash component within the company’s broader resource base. Total assets were 3.4% higher than fiscal 2024 assets of $171.17M, measuring the company’s own balance-sheet change.

Cash Flow and Earnings Quality

Cash flow from operations was $18.71M, a reported cash inflow that can be compared directly with net income and capital spending. The operating-cash-flow-to-net-income relationship was 3.65x, comparing cash generated by operations with the bottom-line earnings result. Capital expenditures used $58.00K, identifying the reported investment outflow deducted from operating cash flow in the free-cash-flow calculation. Capital spending absorbed 0.3% of operating cash flow, quantifying the share of cash from operations directed to investment. Free cash flow came to $18.66M, leaving a positive amount after capital expenditures. The free-cash-flow margin was 17.0%, measuring cash remaining after capital spending against revenue. The free-cash-flow-to-assets relationship was 10.5%, comparing post-investment cash with the balance-sheet asset base.

Based on the annual report for the fiscal year ending Dec 31, 2025. Analysis generated Oct 21, 2026.